Exogenous Insulin Infusion Can Decrease Atherosclerosis in Diabetic Rodents by Improving Lipids, Inflammation, and Endothelial Function
Kyoungmin Park(Joslin Diabetes Center), George L. King(Joslin Diabetes Center), Net Daş Evcimen(Ankara University), Hillary A. Keenan(Joslin Diabetes Center), Ronald St-Louis(Joslin Diabetes Center), Mogher Khamaisi(Joslin Diabetes Center), Daniel Gordin(Helsinki University Hospital), Takanori Shinjo(Kyushu Dental University), Yasutaka Maeda(Kyushu University), David Pober(Joslin Diabetes Center), Christian Rask‐Madsen(University of Ulsan), Ernesto Maddaloni(Oxford Centre for Diabetes, Endocrinology and Metabolism), Hisashi Yokomizo(Joslin Diabetes Center), Qian Li(Beijing Wuzi University), Jialin Fu(Joslin Diabetes Center)
Cited by 55
Related Papers
Vascular Endothelial Growth Factor in Ocular Fluid of Patients with Diabetic Retinopathy and Other Retinal Disorders
|New England Journal of Medicine|1994|3.8k
Suppression of retinal neovascularization in vivo by inhibition of vascular endothelial growth factor (VEGF) using soluble VEGF-receptor chimeric proteins.
|Proceedings of the National Academy of Sciences|1995|1.3k
Retinopathy in Diabetes
|Diabetes Care|2004|1.1k
Activation of Protein Kinase C Isoforms and Its Impact on Diabetic Complications
|Circulation Research|2010|979